Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| PHARVARIS N V COM | 4,289,304 | 4,639,304 | +350,000 | 75,492 | 115,751 | 65.62% | +40,259 |
| ALX ONCOLOGY HLDGS INC(ALXO) | 9,699,925 | 9,699,925 | 0 | 4,026 | 17,751 | 10.06% | +13,724 |
| ALUMIS INC | 4,619,803 | 4,619,803 | 0 | 13,859 | 18,433 | 10.45% | +4,574 |
| LYELL IMMUNOPHARMA INC(LYEL) | 473,479 | 473,479 | 0 | 4,186 | 7,689 | 4.36% | +3,504 |
| ARTIVA BIOTHERAPEUTICS INC(ARTV) | 1,148,975 | 1,148,975 | 0 | 1,735 | 3,298 | 1.87% | +1,563 |
| HARMONY BIOSCIENCES HLDGS IN(HRMY) | 489,194 | 489,194 | 0 | 15,459 | 13,482 | 7.64% | -1,976 |